Clinical Trials Directory

Trials / Completed

CompletedNCT01895634

Reperfuse Ischemic Vessels With Endovascular Recanalization Device in JAPAN (RIVER JAPAN)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Johnson & Johnson K.K. Medical Company · Industry
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The main objective of this study is to document that the thrombectomy catheter (Rev-01) is effective and safe when used for revascularization in subjects with acute ischemic stroke within 8 hours of symptom onset who are ineligible for treatment with IV t-PA, or in whom treatment with IV t-PA has been ineffective.

Conditions

Interventions

TypeNameDescription
DEVICERev-01Treatment arm patients have used Rev-01 at least once

Timeline

Start date
2013-05-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2013-07-10
Last updated
2016-03-07
Results posted
2016-02-05

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01895634. Inclusion in this directory is not an endorsement.